|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 141 | 2003 | Validation of biomarkers as surrogates for clinical endpoints | BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc; RENARD, Didier; BURZYKOWSKI, Tomasz; GEYS, Helena; MOLENBERGHS, Geert | Book Section | B3 |
| 142 | 2003 | Comparaison entre LV5FU2 bi-mensuel et FUFOL mensuel pendant 24 ou 36 semaines en traitement adjuvant des cancers du colon stade II et III: résultats à 4 ans d'une étude randomisée | BUYSE, Marc; André, Thierry; Artru, P.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Piedbois, P.; Flesch, M.; Tubiana-Mathieu, N.; de Gramont, A. | Journal Contribution | A2 |
| 143 | 2003 | Simplified hierarchical linear models for the evaluation of surrogate endpoints | TIBALDI, Fabian; CORTINAS ABRAHANTES, Jose; MOLENBERGHS, Geert; RENARD, Didier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Parmar, Mahesh; Stijnen, Theo; Wolfinger, Russ | Journal Contribution | A1 |
| 144 | 2003 | Using the 'expected' survival to explain differences between the results of randomized trials: a case in advanced ovarian cancer | BUYSE, Marc; BURZYKOWSKI, Tomasz; Parmar, Mahesh; Torri, Valter; Omura, George; Colombo, Nicoletta; Williams, Chris; Conte, Pierfranco; Vermorken, Jan | Journal Contribution | A1 |
| 145 | 2003 | Validation of a longitudinally measured surrogate for a time-to-event endpoint | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc; VANGENEUGDEN, Tony; BIJNENS, Luc | Journal Contribution | A1 |
| 146 | 2003 | Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial | BUYSE, Marc; André, Thierry; Colin, P.; Liouvet, C.; Gamelin, E.; Bouche, O.; Achille, Emmanuel; Colbert, N.; Boaziz, C.; Piedbois, P.; Tubiana-Mathieu, N.; Boutan-Laroze, A.; Flesch, M.; Billau, V.; de Gramont, A. | Journal Contribution | A1 |
| 147 | 2002 | Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early cancer: first results of the ATAC randomized trial | BUYSE, Marc | Journal Contribution | A1 |
| 148 | 2002 | Statistical challenges in the evaluation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel | Journal Contribution | A1 |
| 149 | 2002 | Challenges in the methodology for the validation of surrogate endpoints in randomized trials | MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier; BURZYKOWSKI, Tomasz | Proceedings Paper | C2 |
| 150 | 2002 | The role of colony stimulating factors in small cell cancer: why the question is still unresolved | Trillet-Lenoir, V.; Piedbois, R.; BUYSE, Marc | Journal Contribution | A1 |
| 151 | 2002 | Equivalence between ovarian suppression and chemotherapy in the adjuvant treatment of endocrine-responsive breast cancer | DiLeo, A.; BUYSE, Marc | Journal Contribution | A1 |
| 152 | 2002 | Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes | RENARD, Didier; GEYS, Helena; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 153 | 2001 | Methodology for the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 154 | 2001 | Methodology of the validation of surrogate endpoints in multiple randomized experiments | MOLENBERGHS, Geert; ALONSO ABAD, Ariel; BURZYKOWSKI, Tomasz; CORTINAS ABRAHANTES, Jose; GEYS, Helena; RENARD, Didier; SHKEDY, Ziv; TIBALDI, Fabian; BUYSE, Marc | Proceedings Paper | C2 |
| 155 | 2001 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Journal Contribution | A1 |
| 156 | 2001 | Re: A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer | BUYSE, Marc; Thirion, Pierre; Carlson, Robert; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 157 | 2001 | Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes | MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc | Journal Contribution | A1 |
| 158 | 2001 | Should Dukes' B patients receive adjuvant therapy? A statistical perspective | BUYSE, Marc; Piedbois, P | Journal Contribution | A1 |
| 159 | 2000 | Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints | BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; BUYSE, Marc; GEYS, Helena; RENARD, Didier | Proceedings Paper | C1 |
| 160 | 2000 | Randomized designs for early trials of new cancer treatments - An overview | BUYSE, Marc | Journal Contribution | A1 |
| 161 | 2000 | Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis | BUYSE, Marc; Thirion, Pierre; Carlson, Robert W.; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; Piedbois, Pascal | Journal Contribution | A1 |
| 162 | 2000 | Meta-analysis: Methods, strengths, and weaknesses | BUYSE, Marc; Piedbois, P; Piedbois, Y; Carlson, RW | Journal Contribution | A1 |
| 163 | 2000 | R-2: A useful measure of model performance when predicting a dichotomous outcome | BUYSE, Marc | Journal Contribution | A1 |
| 164 | 2000 | Fraud in medical research: An international survey of biostatisticians | Ranstam, J.; BUYSE, Marc; George, S.L.; Evans, S.; Geller, N.; Scherrer, B.; LESAFFRE, Emmanuel; Murray, G.; Edler, L.; Hutton, J.; Colton, T.; Lachenbruch, P. | Journal Contribution | A1 |
| 165 | 2000 | Statistical validation of surrogate endpoints: problems and proposals | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 166 | 2000 | Corrigendum to "The validation of surrogate endpoints in randomized experiments" | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 167 | 2000 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Journal Contribution | A1 |
| 168 | 1999 | The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials | BUYSE, Marc; George, SL; Evans, S; Geller, NL; Ranstam, J; Scherrer, B; LESAFFRE, Emmanuel; Murray, G; Edler, L; Hutton, J; Colton, T; Lachenbruch, P; Verma, BL | Journal Contribution | |
| 169 | 1999 | Meta-analyses of published results are unreliable | BUYSE, Marc; Carlson, RW; Piedbois, P | Journal Contribution | |
| 170 | 1999 | The validation of surrogate endpoints in meta-analyses of randomized experiments | BUYSE, Marc; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; RENARD, Didier; GEYS, Helena | Proceedings Paper | |
| 171 | 1999 | The role of anthracyclines in epithelial ovarian cancer | Vermorken, J.B.; Harper, P.G.; BUYSE, Marc | Journal Contribution | |
| 172 | 1998 | Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production | Corazza, F.; Beguin, Y.; Bergman, P.; André, M.; Fersten, A.; DE VALCK, Chris; Fondu, P.; BUYSE, Marc; Saribau, E. | Journal Contribution | |
| 173 | 1998 | Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced coloractal cancer | BUYSE, Marc | Journal Contribution | |
| 174 | 1998 | Toxiicity of 5-fluorouacil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors | BUYSE, Marc | Journal Contribution | |
| 175 | 1998 | Homeopathy | BUYSE, Marc | Journal Contribution | |
Loading...
5
0
5
0
false